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Abstract
Background: Malaria is a leading cause of morbidity and mortality in children younger than 5 years in Kenya.
Within the context of planning for a vaccine to be used alongside existing malaria control methods, this study
explores sociocultural and health communications issues among individuals who are responsible for or influence
decisions on childhood vaccination at the community level.
Methods: This qualitative study was conducted in two malaria-endemic regions of Kenya–South Coast and Busia.
Participant selection was purposive and criterion based. A total of 20 focus group discussions, 22 in-depth
interviews, and 18 exit interviews were conducted.
Results: Participants understand that malaria is a serious problem that no single tool can defeat. Communities
would welcome a malaria vaccine, although they would have questions and concerns about the intervention.
While support for local child immunization programs exists, limited understanding about vaccines and what they
do is evident among younger and older people, particularly men. Even as health care providers are frustrated
when parents do not have their children vaccinated, some parents have concerns about access to and the quality
of vaccination services. Some women, including older mothers and those less economically privileged, see
themselves as the focus of health workers’ negative comments associated with either their parenting choices or
their children’s appearance. In general, parents and caregivers weigh several factors–such as personal opportunity
costs, resource constraints, and perceived benefits–when deciding whether or not to have their children
vaccinated, and the decision often is influenced by a network of people, including community leaders and health
workers.
Conclusions: The study raises issues that should inform a communications strategy and guide policy decisions
within Kenya on eventual malaria vaccine introduction. Unlike the current practice, where health education on
child welfare and immunization focuses on women, the communications strategy should equally target men and
women in ways that are appropriate for each gender. It should involve influential community members and
provide needed information and reassurances about immunization. Efforts also should be made to address
concerns about the quality of immunization services–including health workers’ interpersonal communication skills.
Background
Despite progress in fighting malaria worldwide, the
parasitic disease kills close to 800,000 people annually
[1]. In Kenya, an estimated 27 million people (about 70
percent of the population) are at risk of infection, and
roughly 34,000 young children die of malaria-related
causes annually [2]. Current interventions in Kenya
include the use of long-lasting insecticide-treated nets,
indoor residual spraying with insecticides, intermittent
preventive therapy with sulphadoxine-pyrimethamine for
expectant mothers, and artemisinin-based combination
therapies for malaria case management [2].
Recent advances in malaria vaccine development have
heightened the possibility that, if proven effective, a new
anti-malaria tool could be deployed for use alongside
existing interventions [3]. A vaccine candidate targeting
the most life-threatening malaria parasite, Plasmodium
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any medium, provided the original work is properly cited.falciparum, is moving through a Phase 3 efficacy trial in
Kenya and six other African countries–Burkina Faso,
Gabon, Ghana, Malawi, Mozambique, and Tanzania [3].
Data from previous studies indicate that this vaccine
candidate–GlaxoSmithKline Biologicals’ RTS, S–may cut
episodes of clinical malaria in young children by about
half [4]. If the efficacy trial confirms earlier findings, the
World Health Organization (WHO) has indicated that a
policy recommendation for RTS, S is possible as early as
2015, paving the way for implementation in countries
through their expanded programs on immunization.
Final results from the trial are expected in late 2014.
But experience has shown that licensing a new health
intervention hardly guarantees its timely use. In develop-
ing countries, it has taken up to two decades for new vac-
cines to become available to communities after they are
licensed [5]. Similarly, while the malaria vaccine commu-
nity’s 2015 mark for a first-generation product [6] may
be within reach, the actual introduction and use of a new
vaccine could be held up for years because of a variety of
factors. For example, the absence of critical data could
slow down the process that policymakers must undertake
to determine whether or not to introduce a particular
intervention into their health systems [7]. In addition,
misinformation within communities or poorly handled
information by decision-makers could result in an out-
right lack of support for an intervention by local commu-
nities even after it has been introduced [8].
The formative study described in this paper is meant
to address these communications needs. Information
gathered is meant to add to the range of well-timed
data required by policymakers to reach a decision on
whether or not to add a malaria vaccine to their existing
methods [7]. The information is also meant to inform
the design of a communications strategy, including ways
to engage communities well before a malaria vaccine
becomes available. This paper presents the results of the
study in Kenya within the context of informed decision-
making related to future malaria vaccines and with an
eye to the elements that should form the basis of a com-
munications strategy, including those factors that poten-
tially motivate or represent constraints to vaccination.
The impetus for this study came from several sources.
The wider malaria vaccine community called for this
information to help African decision-makers better
understand how and whether they should introduce a
malaria vaccine for use with other malaria interventions
[6]. Responding to this call, in 2006, the PATH Malaria
Vaccine Initiative (MVI), WHO, and national immuniza-
tion and malaria control programs in several African
countries outlined the data required to assess the need
for such a vaccine [7]. In addition, WHO’s framework
for new vaccine introduction calls this type of research a
key step toward vaccine introduction, as it provides a
solid evidence base for, among other things, designing
an informed communications strategy [9]. Other experts
have also concluded that it is essential to understand
the relevant sociocultural context for a new health inter-
vention, such as a vaccine, to be successful [10].
The relevant literature on immunization programs and
services in sub-Saharan Africa highlights the important
role of communications. Some research shows that
while communities are generally knowledgeable about
vaccine-preventable diseases, mothers may lack key vac-
cination schedule information, such as how many vacci-
nations their children should receive or by what age
they should have completed the course of vaccines [11].
A communications strategy could also take into account
any beliefs about disease severity that may influence
whether a child is vaccinated.
Other research has pointed to the importance of com-
munications on issues around access to services, such as
the distance that some families must travel for vaccina-
tion at primary health care facilities [12] and interac-
tions between vaccination providers and users. A
distrustful climate between communities and immuniza-
tion programs can contribute to growing pools of non-
immunized and partially immunized children [13-15].
Recent research also points to the key role that trusted
sources or opinion leaders can play in fostering accep-
tance for vaccination [16]. In this regard, health care
providers are themselves seen as important influencers
of parents and other caregivers [15].
With all this in mind, the African Medical and
Research Foundation (AMREF) in Kenya worked with
MVI to explore sociocultural and health communica-
tions issues among individuals at the community level–
both those responsible for decisions about vaccine use
and those likely to influence such decisions. The study’s
objectives were also closely tied to the need to identify
and describe target audiences and to highlight the rele-
vant beliefs, values, attitudes, knowledge, and behaviors
of these audiences prior to the introduction of an inter-
vention [17]. The study therefore had the following spe-
cific objectives:
￿ To determine the perceptions, beliefs, practices,
and information gaps related to malaria and vaccines
among caregivers, service providers, and others at
the community level.
￿ To determine household decision-making and
treatment-seeking patterns related to malaria and
vaccination.
￿ To identify key audiences and communications and
information channels at the community level.
Given these objectives, it is nevertheless important to
emphasize that this study should be seen as formative in
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tions of vaccination in relation to possible malaria vac-
cine introduction.
Methods
Site selection
The formative study was conducted in two regions of
Kenya. Sites were selected based on a variety of factors,
with the primary and secondary factors being malaria
endemicity and local community and stakeholder support
for conducting the study. High endemicity was sought to
obtain data rich in experiences with malaria. Thereafter,
variations in data were sought based on criteria such as
ability to sample rural and urban populations, diversity in
ethnic groups, and variation in religion.
The two study regions selected were the larger Busia
region in Western Province and South Coast in Coast
Province. Busia, situated in the Uganda-Kenya border
region near Lake Victoria, is considered a highly endemic
malaria region with year-round transmission [18]. Within
the Busia region, study participants resided in the follow-
ing areas: Busia Township, Bunyala, Samia, Butula, and
Nambale. This predominantly Christian region is primar-
ily home to the Luhya tribe. Dominant languages spoken
by study participants were Luhya and Kiswahili.
The South Coast region is considered highly endemic
with perennial malaria transmission; however, more
recent data indicate that malaria is declining in the
region [19]. The rural and urban areas sampled included
Kwale, Kinango, Msambweni, and Mombasa. The South
Coast region has greater Arab influence, is of Swahili
culture, and has a higher proportion of Muslims than
other parts of the country. Languages spoken by study
participants were Digo, a dialect of the Mijikenda lan-
guage, and Kiswahili.
Participant selection and data collection
Participant selection was largely purposive and criterion
based. Criteria were based on a literature review and an
ecological conceptual framework, commonly used in
health planning formative studies [20]. This framework
was successfully adapted for use by PATH in other new
child vaccine planning studies [21]. The framework
recognizes levels or categories of people who influence
whether a child is immunized. These levels constitute
important target audiences for developing a health com-
munications strategy aimed at engaging communities in
new vaccine introduction activities. They include:
1. The individual level: Parents and other caregivers
of children.
2. The interpersonal level: Secondary influencers
such as teachers, health workers, and the media and
other communicators.
3. The community level: Community leaders, local
administrators, and local government officials.
4. The institutional level: Health care personnel and
administrators.
Seven research assistants (four in the Coast region and
three in the Busia region) were recruited for data collec-
tion. All seven (three men and four women) had degrees
in related social sciences and had prior experience with
qualitative interviewing. They were native speakers of the
relevant local languages and speakers of the second
national language, Kiswahili. Training of the research
assistants and pre-testing of tools were carried out in
October 2009. The training, which took place in the
coastal city of Mombasa, covered an introduction to
MVI’s Community Perceptions Study and a re-orientation
on such qualitative research approaches as data collection,
obtaining informed consent, and analysis. Study tools were
also reviewed, translated, and back-translated. Thereafter,
pilot-testing was completed in the Coast region, and data
collection activities began in November 2009. All activities
were monitored by senior research staff.
A total of 20 focus group discussions (FGDs) were
held, with 234 participants; 22 key informant interviews
were conducted; and 18 exit interviews were completed
in maternal and child health clinics (Table 1). FGDs
were held with similarly situated respondents (e.g.,
mothers between 18 and 24 years of age) in an effort to
solicit more candid responses. In addition, data were
collected on vaccine delivery, immunizations, and
administrative services from the health facilities visited.
FGDs and in-depth interviews were both noted and
recorded, then later transcribed and translated from the
local languages–Luhya, Digo, and Kiswahili–to English.
Researchers carried out thematic content analysis using a
codebook process on the translated English transcripts. To
ensure maximum data validity and verification of findings
at different levels, two iterations of analysis were conducted.
Researchers first reviewed the transcripts for key themes
using an iterative discursive process and developed a master
codebook. At the second level, the researchers worked with
an analyst versed in Atlas. ti software to code the data elec-
tronically and then generate reports to further explore the-
matic relationships and variations in the data by site, age,
category of focus group participants, and type of interview.
Ethics approval
The study was reviewed in Kenya by the AMREF Ethics
and Scientific Review Committee and in the United
States by the PATH Research Ethics Committee.
Results
Results are organized in three general thematic areas:
perceptions of and experiences with malaria; perceptions
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erations for a future malaria vaccine (Table 2). Since the
analysis included a comparative examination of findings
by region, gender, and study group, observable differ-
ences are highlighted where they exist.
Sociodemographic characteristics of study participants
Participants resided mainly in rural areas, though some
lived in the urban slum areas of Mombasa. Among par-
ents and community representatives, small-scale farming
and small business were common occupations. Those
with formal employment included pharmacists, health
care providers, and government officials. Income varia-
tions were notable by age group and region. For partici-
pants older than 50, remittances by children were cited
as a main source of income. And while cross-border,
small business was common in Busia, income stemming
from the tourist industry in the Coast was noted.
Perceptions of and experiences with malaria
Malaria is a serious health concern
Overall, malaria appeared to be well known to the com-
munity. Study participants shared their experiences with
the disease from the perspective of parents who had lost
children, caregivers for other family members, observers
of patients, and patients themselves. Participants in all
groups noted that malaria was a serious health problem
that could lead to the deaths of adults and children,
cause weight loss, and contribute to poor school perfor-
mance. The consensus across the groups that malaria
Table 1 Sampling framework and final sample size
Busia region South Coast region/Mombasa district Number
of
events
Focus group discussions
Mothers 50+ years old Mothers 50+ years old
Fathers 50+ years old Fathers 50+ years old
Mothers 25-49 years old (2 groups) Mothers 25-49 years old (2 groups)
Fathers 25-49 years old Fathers 25-49 years old
Mothers 18-24 years old Mothers 18-24 years old
Fathers 18-24 years old Fathers 18-24 years old
Mothers 18-49 years old Mothers 18-49 years old
Fathers 18-49 years old Fathers 18-49 years old
Community health workers Community health workers 20
Key informant interviews
Woman leader, youth leader, assistant chief, pastor, teacher,
shopkeeper, traditional birth attendant, civil society organization
representative, district public health officer, district nutritionist
Woman leader, youth leader, chief, pastor, imam, traditional birth
attendant, civil society organization representative, teacher, local
pharmacist, district public health officer, district medical officer,
district public health nurse
22
Clinic exit interviews
Mothers in an antenatal clinic (3) Mothers in an antenatal clinic (3)
Mothers in a child welfare center (3) Mothers in a child welfare center (3)
Mothers with febrile children (3) Mothers with febrile children (3) 18
Total 60
events
Table 2 Themes explored in the study
Theme Thematic areas explored
1. Perceptions and experiences with malaria ￿ Perceptions of women and men around malaria.
￿ Perceived causes of malaria.
￿ Community experiences with malaria control efforts.
2. Perceptions and experiences with child
immunization
￿ Community experiences with vaccination programs and the health system.
￿ Community perceptions of factors that influence immunization coverage and acceptance of a
new vaccine.
￿ Decision-making around child vaccination.
3. Considerations for a future malaria vaccine ￿ Reactions to the prospect of a new vaccine.
￿ Expectations for a new vaccine.
￿ Concerns about a possible new vaccine.
￿ The concept of efficacy.
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is reflected in an older father’s comment:
Malaria has really affected my family, and as we are
talking, I have two children who are suffering from
malaria. I brought them to the hospital and they
were treated for malaria; I went back home with
them and they improved. After a while, they got
malaria again and I came back to the hospital and
they were treated, but again they got malaria once
more after getting back home. Now, my earnings are
affected because coming to the hospital is money and
it becomes difficult to bring them back to the hospital
since money is a problem. (Participant, FGD fathers
50+, Coast region)
Participants recognized a similar cluster of symptoms
of malaria across settings. In addition, fever may some-
times be equated with malaria and consequently, other
illnesses that manifest fever as a symptom may also be
described as malaria. The most commonly mentioned
symptoms included headaches, body aches, fever, con-
vulsions, vomiting, diarrhea, dehydration, loss of appe-
tite, weight loss, low blood levels, red eyes, coughing,
sneezing, fast breathing, restlessness, and depression.
Some participants also referenced temporary madness
(during severe episodes of malaria).
Who is at risk for malaria?
Although everyone was said to be at risk for malaria,
focus group discussants generally recognized that groups
who were particularly vulnerable to the disease included
poor people and children–those between 9 months and
5 years of age, those younger than 15 years, and new-
borns. The antenatal and postnatal periods were identi-
fied as risk periods for the mother.
What causes malaria?
Most study participants understood that malaria is
transmitted by mosquitoes. At the same time, parents in
FGDs identified a number of factors as traditionally
accepted causes of malaria, especially among children.
For some, simply overeating or eating certain plant
foods, such as raw mangoes, groundnuts, and young
sugar cane, was reported as associated with getting
malaria. Many parents also cited cold-water baths and
weather-related causes, including exposure to dew and
rain and spending the night in cold conditions (as is
usually the case during funerals). In the Busia region,
participants from the flood-prone district of Bunyala
attributed high malaria incidence to flood waters.
The “forces of evil” as a cause of malaria emerged as
an important perception in both regions. Mainly articu-
lated in FGDs involving older participants, this percep-
tion was also highlighted by community health workers,
who have a keen understanding of their communities.
This factor was also more frequently cited in the Coast
region, compared with Busia. In this regard, the nyuni
(a bird) was often reported to be a common cause of
malaria, as were evil spirits, known in the coastal Digo
language as tsagwa. Going against cultural prohibitions–
such as a woman having sexual relations soon after
birth–was also seen to cause malaria. Professionals such
as teachers, health care providers, and pharmacists in
both South Coast and Busia tended to cite the scientific
causes of the disease (e.g., bites by infectious mosqui-
toes), rather than these traditional beliefs.
Preventing malaria-like illnesses
Parents in the two regions appeared to be engaged in
similar practices to prevent malaria in their children.
Sleeping under mosquito nets was reported to be one of
the best malaria control methods. However, parents
noted that nets may not always be affordable or avail-
able and that using them mayb ei n c o n v e n i e n t .O t h e r
anti-malaria measures for parents in both the Busia and
Coast regions included keeping the house and surround-
ings clean, indoor and outdoor spraying with insecti-
cides, the use of mosquito repellent jelly and mosquito
coils, drainage of stagnant water, and the pouring of
paraffin oil on water to kill larvae. They also reported
keeping doors and windows closed during the evenings
and the indoor burning of cow dung, ubani (incense),
and the leaves of the obengele, obwali,o rmvumbani
trees to repel mosquitoes.
Treating malaria-like illnesses
While study participants talked about taking sick chil-
dren to clinics, the first steps in managing malaria-like
illnesses often appeared to be home based. First-line
malaria care therapies for some involved the purchase of
non-prescribed painkillers such as Panadol and Calpol.
The use of herbs and traditional healers was also com-
monly mentioned across groups and settings, with parti-
cipants saying that families often took children to
traditional healers when home-based treatment was not
effective. Some parents reported that children may be
bathed in cold water to bring down temperatures, cov-
ered with blankets, or given large quantities of boiled
water to drink. In one FGD in the Coast region, parents
explained that a mother may have the sick child lie flat
and urinate on him to cool his temperature.
Perceptions of and experiences with child immunization
Perceptions and experiences with regard to having
children vaccinated were explored in several ways dur-
ing the FGDs and interviews. Thematic areas included
decision-making within households related to child
health and immunization, knowledge and previous
experiences with vaccines and immunization efforts in
Kenya, and perceived benefits of and constraints to
child immunization.
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Results indicated that decision-making related to child
vaccination varies. In the Coast region, parents said the
decision usually fell to the father or to another adult
male household member. In Busia, parents generally
agreed that mothers were the ones who usually decided
whether or not to vaccinate a child:
It is the mother who mostly decides, because when
they go to clinic, they are taught about various types
of vaccinations and their sequencing, including dates.
(Participant, FGD older fathers, Bunyala, Busia)
Some study participants had more nuanced answers on
the question of who might decide whether or not to have
a child vaccinated. They noted that in some instances, the
family as a whole, including the extended family, may be
involved in such a decision. In many situations, who
makes the decision may depend on who is the main
income earner, how busy the mother is at home, and who
can provide transportation for the mother and child. Some
participants noted that the family may also be influenced
by a broader network of people that includes neighbors,
community leaders, and health workers (see Table 3).
Knowledge of local immunization programs
In general, parents were aware of local immunization
programs and could name different diseases for which
children are vaccinated. Pharmacists were more knowl-
edgeable than parents about these programs. Older and
younger men tended to demonstrate less knowledge
about immunization programs than their male and
female counterparts in the 25-49-year-old group.
Benefits of vaccination
Focus group participants and in-depth interviewees in
both research settings generally reacted positively to the
idea of having children vaccinated. For example, one of
the chiefs interviewed explained that nothing he knew
about vaccines would deter him from accessing the ser-
vices, and a women’s leader said she knew it was her
r e s p o n s i b i l i t yt ot a k eh e rc h i l dt ob ev a c c i n a t e d .S i m i l a r
views were shared in FGDs with older women and
younger parents, who explained that they had not experi-
enced major problems in accessing vaccination services.
The majority of discussants held the view that the
main benefit of immunization was avoidance of disease-
related child death and disability and reduction in the
severity of disease. Some participants said they under-
s t o o dt h a tv a c c i n e sw o r k e df o ral i m i t e dt i m e ,w h i l e
others said that vaccines ensured that children did not
get infections too frequently. Some misconceptions
among parent FGD discussants included statements that
vaccines can cure diseases. In addition, community
health workers in one focus group in Busia reported
that mothers sometimes confused vitamin A injections–
given to babies during Malezi Bora (good nurturing)
Week–with vaccination.
Motivating factors related to immunization
Many of the perceived benefits of immunization were
also seen as motivating factors for getting children vac-
cinated. Within this context, parents pointed to their
understanding that vaccines protected children from
specific dreaded diseases. Parents in both the Coast and
Busia regions also voiced appreciation for the health
education provided by service providers about vaccina-
tion, and they welcomed the endorsement of influential
community members, including chiefs and religious lea-
ders. Some parents, particularly mothers, said that see-
ing a health care provider for vaccination might provide
an added benefit to their children in the detection of
previously undiagnosed health problems.
Constraints to child immunization
While parents were generally positive about Kenya’s
immunization programs, they also provided insights into
why some children may not get vaccinated. In this
regard, many pointed to a lack of understanding among
some people of the benefits of vaccination:
There are those who if they are told that there is a
vaccine being given, they do not go. They say, “What
is it for?” They do not understand what it is for,
therefore do not let their children go for it. (Partici-
pant, FGD fathers 50+, Kinango, Coast)
Table 3 Those likely to motivate others to access vaccination services
Primary influencers Secondary influencers
￿ Community health workers ￿ Mothers-in-law
￿ Health care providers (doctors, nurses) ￿ Grandmothers
￿ Neighbors ￿ Councils of elders
￿ Village elders ￿ Traditional healers
￿ Mass media ￿ School-going children
￿ Local or provincial government administrations (including chiefs and assistant
chiefs)
￿ Mother-to-mother support groups￿
￿ Ministry of Medical Services ￿ Representatives of non-registered immigrants and nomadic
communities
￿ Ministry of Public Health and Sanitation ￿ The elite within society (professionals/professional organizations)
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perspective, pointing to the role of mothers-in-law:
They may argue their son (now father to her grand-
son) was not vaccinated and yet he is strong and
healthy. (Participant, FGD community health work-
ers, Butula, Busia)
Among constraints to immunization, parents in FGDs
in both Busia and the Coast voiced a variety of concerns
about the potential side effects of vaccination and about
perceived injection practices. Side effects described as
common included soreness at the vaccination site and
slight fevers, while serious side effects included abscesses
at the vaccination site, which were attributed to poor
injection technique. Parents in both Busia and the Coast
said that they preferred to be served by experienced ser-
vice providers as opposed to “dressing staff,” and some
participants said they were concerned that needles and
syringes were reused on different children. In a related
concern, several participants suggested that parents may
worry about taking children to be vaccinated because
they fear the child might become infected with HIV
through unsafe injection practices. Parents in Busia and
the Coast also highlighted fears that the government
may be using vaccines to sterilize young female children
or to reduce the population.
Certain traditional cultural practices may inhibit
timely immunization, especially with regard to vaccines
given soon after birth. In the Busia region, study partici-
pants reported that mothers who deliver at home are
required to keep the baby indoors for three to four days
after birth (three days for a girl, four days for a boy). In
addition, some mothers do not like their children to be
weighed naked during a check-up or to have them share
the weighing basket with others. Study participants
noted that some religious denominations also forbid
childhood immunization.
Complaints about access to vaccine services were voiced by
parents in both Busia and the Coast
While parents could list places where children could be
vaccinated, some felt that clinic services were at times
difficult to access. Some also said they did not get suffi-
cient advance notice about vaccination days. Parents
and other caregivers also complained of the inconveni-
ence of traveling to a clinic and then waiting for hours
only to be told that services were not available because
of stockouts of vaccines and other drugs. For their part,
many service providers interviewed said they were
sometimes unwilling to open vaccine vials with short
expiration dates if there were not enough children to
use all the doses.
The perceived attitudes of some service providers
toward patients also appeared to affect willingness to
attend a clinic. Some parents were reportedly concerned
that they could be criticized for not dressing their chil-
dren well, for following traditional health practices, or
for having babies wear items to protect them against
harm. Young fathers in Busia Township explained that
d i r t yc l o t h e sw o r nb yac h ild or mother or failure to
cover a baby with a shawl sometimes elicited criticism
from service providers. Several mothers also feared that
they would not be welcome at vaccination centers
if they had not shown up for antenatal care or had
not delivered their babies at a clinic.
Participants in several parent FGDs suggested that
some women seemed to be the focus of negative reac-
tions at vaccination centers for reasons that had to do
with their parenting choices. Reports of some mothers
being scolded by health care providers or even other
women for having given birth at close intervals, for hav-
ing several children to vaccinate at the same time, or for
being pregnant while still breastfeeding were heard dur-
ing FGDs with parents in all age groups and settings.
For mothers in Samia, being pregnant past the age of 45
was said to elicit frowns and scorn at vaccination
centers.
For their part, service providers spoke of feelings of
frustration when parents did not come in for vaccina-
tion. Such frustration could lead to unfriendliness or
scolding. Some providers and many parents described
families who had not taken their children to be immu-
nized as “lazy,”“ ignorant,” or “difficult.” A Busia health
worker captured the frustrations of other health care
providers:
They are careless parents. Continued visitation or
education through a close friend will help change
them. Such parents do not have proper knowledge of
the benefits of vaccines. Education should be done
through local barazas (formal open meetings called
by local area chiefs and other administrators) and
churches for them, to help protect the life of the inno-
cent child. (Participant, FGD community health
workers, Butula, Busia)
Parents’ instinctive calculation of opportunity costs
and benefits often influences whether or not they take
their children to be vaccinated. A closer look at the
study data indicates that parents, particularly women
in the Coast region, are strongly motivated when vac-
cinations are free, when no payments are required at
the clinic, and when incentives, such as bed nets, are
provided. For some mothers in Busia, the real motiva-
t i o ni sn o tt h a tt h ec h i l ds h o u l db ev a c c i n a t e d ,b u t
rather the desire for bed nets, food, milk, or other
f r e eg o o d sp r o v i d e da si n c e n t i v e sd u r i n gv a c c i n a t i o n
sessions.
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During FGDs, key informant interviews, and clinic exit
interviews, field researchers oriented participants on
progress in malaria vaccine development and asked
them to respond to the prospect of a malaria vaccine.
By and large, participants were excited about the poten-
tial of a malaria vaccine, with no major differences
found by region, gender, or age group. At the same
time, questions and concerns surfaced.
Reactions to the possibility of a malaria vaccine
Responses generally reflected the view that a malaria
vaccine would bring added health benefits. Many partici-
pants, including district health officers, noted that com-
munities would welcome such a vaccine if it were easily
accessible. In many discussions, parents did not see a
problem with a new vaccine “fitting in” with existing
control measures. Parent discussants commonly held the
view that reductions in the number and severity of
malaria cases would indicate that a vaccine was working.
These comments by a Busia father and a Coast mother
sum up some of the reactions:
It will complement the existing interventions. The
vaccine, net, and cleanliness should be combined to
fight malaria. (Participant, FGD fathers 50+,
Bunyala, Busia)
There is a lot of malaria in Kinango, especially now
during the rainy season.... Therefore, if that vaccine
comes, all of us will feel some relief. And we are
really eager for it! [Laughter] (Participant, FGD
mothers 25-49, Kinango, Coast)
Specific questions and concerns
Participants also expressed concerns and raised ques-
tions about a malaria vaccine. Some parents worried
that introduction of a vaccine could signal that current
malaria drugs were no longer effective. Others won-
dered whether the availability of a vaccine could reduce
the need for bed nets. Some participants were more
guarded in their response to the possibility of a malaria
vaccine, suggesting that whether or not they accepted
one would depend both on the advice they received
from service providers (collectively referred to as “doc-
tors”) and on what they observed about the vaccine’s
effectiveness. In many discussions, parents said they
would want to know where a vaccine was tested, on
whom, and what had become of those on whom it was
tested. Many responses suggested that vaccine develo-
pers should target everyone, including pregnant women
and the elderly and that such a vaccine should be
delivered orally. Commonly asked questions included
how a vaccine would work in the body, when it would
be introduced, and whether it would treat or prevent
malaria (see Table 4).
Expectations for a new vaccine
In brainstorming about what they would like from a
malaria vaccine, FGD participants emphasized the idea
of protection, which they said should be more beneficial
than the protection afforded through existing malaria
interventions. Judging from the data, there was a general
expectation that the protection would last at least six
months; whereas for some, the vaccine should have a
life-long effect. In some discussions, the view that com-
munities would not mind the introduction of a partially
efficacious vaccine was evident. One service provider
n o t e dt h a tm o s tv a c c i n e sd i dn o th a v e1 0 0p e r c e n te f f i -
cacy. Another viewpoint held that as long as a vaccine
boosted people’s immunity (including children’s), per-
centages would not matter. One provider summed up
this view in the following way:
Id o n ’t think they would mind.... [People are not
highly educated and] describing the percentage is not
viable, as long as the child has been immunized....
Even if the efficacy is low, I do not think there will be
Table 4 Information needs related to a future malaria
vaccine
Information requested by all participants
￿ Malaria prevalence rates.
￿ Expected benefits of the vaccine.
￿ Whether the vaccine would prevent or cure disease.
￿ Whether the vaccine would provide complete or partial protection.
￿ Number of doses needed.
￿ Mode of administration.
￿ Possible side effects of the vaccine.
￿ How the vaccine would work; how it would differ from other vaccines
in use.
￿ Whether the vaccine would be for children only or for pregnant
women and others as well.
￿ Ages of children to be vaccinated.
￿ Duration of protection and need for booster doses.
￿ Whether the vaccine would be offered at anytime or only during
malaria outbreaks.
￿ Where vaccinations would take place.
￿ Whether people would have to pay for the vaccine.
￿ Whether vaccination would be accompanied by incentives (such as
bed nets).
￿ Manufacturer of the vaccine.
￿ Where and when the vaccine was tested and the outcome.
￿ Whether the vaccine was the result of a governmental or
nongovernmental initiative and which governments support it.
Information requested by health workers only
￿ How to administer the vaccine.
￿ Dosage.
￿ Vaccine storage and handling requirements.
￿ Expiry date.
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of Health, key informant interview, Coast)
Equally numerous, however, were those voices sug-
gesting that a vaccine that is only partly efficacious
could be negatively received by the community. Com-
ments reflecting this view were observed across all study
groups. The data suggest that many participants inter-
preted the concept of efficacy in terms of a “weak” or
“strong” vaccine. For example, a health administrator in
the Busia region said:
The idea of a vaccine that is not strong or effective
enough will discourage people from accessing the ser-
vice for fear of being harmed by the vaccine.( H e a l t h
administrator, key informant interview, Busia)
Similarly, a father in Mombasa stated:
If you show us the weakness of the vaccine, then we
will feel cheated and ignore it. (Participant, FGD
fathers 25-49, Mombasa, Coast)
Concerns around affordability of a new vaccine sur-
faced in many parent discussions. Even though there is
no charge for vaccines in Kenya, participants discussed
affordability within the context of expenses related to
clinic visits; for example, transportation to and from
health facilities and unofficial charges for services at
clinics. Many participants said they felt that a malaria
vaccine should be free and that its adoption should help
households to reduce expenses through a reduction in
malaria-related illnesses. Participants noted that access
to a malaria vaccine should be easy and that it should
be given at the same time as other childhood immuniza-
tions. Others hoped that a malaria vaccine would be
available at all health facilities and that patients would
receive milk or other incentives following vaccination.
Such suggestions were noted more commonly in group
discussions in the Coast region.
Some participants voiced strong opinions on the need
to see community health workers work hand in hand
with service providers to reduce clinic workloads and
wait times. Other ideas reflected the desire for broader
community involvement in vaccination campaigns. For
example, young parents (particularly in the Coast
region) voiced a desire to be involved in campaigns for
a new vaccine.
Discussion
Findings of this study support the view long held by health
economists [22] and more recently by leading social scien-
tists that introducing a health intervention does not, on its
own, guarantee acceptance by communities. In the case of
a vaccine, acceptance may depend on a number of factors
that, if not addressed, may result in suboptimal immuniza-
tion coverage [8,10,14,23-26]. Some of these factors may
constitute potential constraints to vaccination, while
others could potentially enable or motivate those who
influence vaccine use. Still other factors relate to gaps in
information about the intervention or the disease. The
findings of this study highlight the importance of under-
standing these kinds of sociocultural and health communi-
cations issues related to existing malaria interventions and
to vaccination [10,13] in order to inform a communica-
tions strategy and policy decisions regarding vaccine
introduction.
Potential constraining factors
A clear set of issues emerged from this study as poten-
tial constraints to vaccination. Some issues relate to the
overall quality of services at health facilities (congestion,
delays, and the perceived attitudes of some service pro-
viders) and highlight the critical need to fast-track skills-
building related to customer care, especially in light of
increased community awareness of an individual’sr i g h t s
to health [8,13,27]. Studies have shown that sustained
levels of vaccination coverage are only possible when
the quality of services is perceived to be good [13,15]. In
fact, several studies over the past decade have shown
that persistent demand for improved vaccination deliv-
ery services exists worldwide [10,28]. Concerns about
vaccine side effects within the context of concerns about
the health and development of a young child also were
raised by parents in this study, and have been heard
among parents in other low-resource settings [10,14,15].
Potential motivating factors
Participants strongly underscored the roles played by
certain community members and health care workers as
both providers of health-related information and as
endorsers of vaccination services. Of particular signifi-
cance is the potentially influential role of the community
health worker, who is viewed as an extension of the
health delivery system under Kenya’s new community
health strategy. In addition, District Medical Officers of
Health explained that health service providers were
highly regarded by the community and could be key
influencers, particularly in communities with low levels
of health awareness and literacy.
Information gaps
A well-designed communications strategy would be
essential to fostering a supportive environment for an
eventual malaria vaccine. Effective communication
would highlight the characteristics of the new inter-
vention, address community questions and concerns
prior to introduction, and build trust in vaccination
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sages (addressing information needs as well as potential
motivating and constraining factors with regard to vac-
cine use), and it would outline effective ways to deliver
these messages through information channels to identi-
fied target audiences.
Key messages
Results suggest that while there is much on which to
build in terms of current knowledge of the malaria bur-
den and the generally positive image of immunization,
additional information needs exist:
￿ The finding that fever may be equated with malaria
and that other illnesses with fever as a symptom may
be seen as malaria should be addressed. This finding
has implications for how communities may even-
tually judge future malaria vaccine efficacy as well as
efficacy of current malaria control methods.
￿ Specific messaging should highlight the potential
role of a vaccine within a comprehensive malaria con-
trol strategy. This should help to address concerns
that malaria vaccine introduction would be perceived
as obviating the need for other malaria interventions.
￿ Managing expectations about a new vaccine should
be a key aspect of a communications strategy. Parti-
cipants articulated many unrealistic expectations and
assumptions about what an eventual malaria vaccine
might offer.
￿ Specific information about a malaria vaccine
should be provided. Information needs identified
relate to how a new vaccine would work, its safety
profile, duration of protection, when and where to
access the vaccine, and target age groups.
￿ Key messages should aim to strengthen interac-
tions between service providers and community
members, including younger and older parents and
those less economically privileged.
￿ Messages should consider “hidden” costs identified
within communities, such as transportation charges
and unofficial fees for services, as these could
affect the perception of whether or not a vaccine is
affordable.
Target audiences
The results show that parents and other caregivers of
children often are influenced by a broad network of
people within communities in making decisions around
childhood vaccination. This suggests that a communica-
tions strategy supporting vaccine introduction should
target men as well as women, community and health
workers, and political, civic, and religious leaders.
Information channels
Community health workers, traditional healers, and
health care providers emerged as some of the trusted
sources and key influencers within the communities and
should be considered as important channels for health
communication. Shopkeepers and herbalists should also
be considered.
Study limitations
This study has several important caveats to be kept in
mind. To meet the study aims, an exploratory, qualita-
tive approach was employed using criterion-based sam-
pling techniques entailing a small yet carefully selected
sample. The merits of this study should, therefore, be
judged according to standards appropriate for qualitative
research. The findings reflect the experiences of com-
munities located in two regions of Kenya only, the Busia
and South Coast regions of Coast and Western Pro-
vinces. In either case, it is not appropriate to generalize
findings to the entire Kenyan population.
Conclusions
As Kenyan policymakers gather data for decisions on
possible malaria vaccine introduction, a number of fac-
tors should be considered. First, study participants
understand that malaria is a serious problem and that
no single tool can control the disease. Communities
therefore welcome the prospect of a vaccine against
malaria, although they would have questions and con-
cerns about the potential of the new intervention. It is
also noteworthy that when deciding whether or not to
have their children vaccinated, parents weigh a number
of factors, including personal opportunity costs, resource
constraints, and perceived benefits.
The study raises other important points that can
inform both a well-grounded communications strategy
and policy decisions, should a malaria vaccine become
available for use. For instance, while a strong apprecia-
tion for local child immunization programs exists, parti-
cipants have concerns about the quality of services
offered and have ideas about how they can improve.
Such views do not reflect serious dissatisfaction; rather,
they represent empowered communities who worry that
too many children have yet to be reached with immuni-
zation services. Finally, targeted health systems strength-
ening–particularly as it affects interactions between
health care providers and community members–should
be addressed.
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